Filtros : "DOENÇAS CARDIOVASCULARES" "Emirados Árabes Unidos" Removidos: "HIPERTENSÃO" "Noruega" Limpar

Filtros



Limitar por data


  • Fonte: Current diabetes reviews. Unidade: FM

    Assuntos: DIABETES MELLITUS, FATORES DE RISCO, PREVALÊNCIA, DOENÇAS CARDIOVASCULARES

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ATALA, Yeelen Ballesteros et al. Cardiovascular autonomic reflex tests and 7 heart rate variability indices for early diagnosis of cardiovascular autonomic neuropathy in Type 2 diabetes individuals. Current diabetes reviews, v. 18, n. 4, 2022Tradução . . Disponível em: https://doi.org/10.2174/1573399817666210827130339. Acesso em: 02 ago. 2024.
    • APA

      Atala, Y. B., Matos, M. R. D., Zantut-Wittmann, D. E., Castillo, A. R., Santos-Bezerra, D. P., Giannella, M. L. C. C., & Parisi, M. C. R. (2022). Cardiovascular autonomic reflex tests and 7 heart rate variability indices for early diagnosis of cardiovascular autonomic neuropathy in Type 2 diabetes individuals. Current diabetes reviews, 18( 4). doi:10.2174/1573399817666210827130339
    • NLM

      Atala YB, Matos MRD, Zantut-Wittmann DE, Castillo AR, Santos-Bezerra DP, Giannella MLCC, Parisi MCR. Cardiovascular autonomic reflex tests and 7 heart rate variability indices for early diagnosis of cardiovascular autonomic neuropathy in Type 2 diabetes individuals [Internet]. Current diabetes reviews. 2022 ; 18( 4):[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1573399817666210827130339
    • Vancouver

      Atala YB, Matos MRD, Zantut-Wittmann DE, Castillo AR, Santos-Bezerra DP, Giannella MLCC, Parisi MCR. Cardiovascular autonomic reflex tests and 7 heart rate variability indices for early diagnosis of cardiovascular autonomic neuropathy in Type 2 diabetes individuals [Internet]. Current diabetes reviews. 2022 ; 18( 4):[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1573399817666210827130339
  • Fonte: Current drug metabolism. Unidade: FM

    Assuntos: SEROTONINA, DOENÇAS CARDIOVASCULARES, ANTIDEPRESSIVOS, PLACEBOS, INFARTO DO MIOCÁRDIO

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      STELLA, Florindo et al. Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, v. 19, n. 8, p. 641-652, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389200219666171227203225. Acesso em: 02 ago. 2024.
    • APA

      Stella, F., Loureiro, J. C., Pais, M. V., Canineu, P. R., & Forlenza, O. V. (2018). Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, 19( 8), 641-652. doi:10.2174/1389200219666171227203225
    • NLM

      Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1389200219666171227203225
    • Vancouver

      Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1389200219666171227203225
  • Fonte: Current Pharmaceutical Design. Unidade: FCF

    Assuntos: INFLAMAÇÃO, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARANHÃO, Raul Cavalcante e LEITE, Antonio Carlos de Arruda. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, v. 21, n. 9, p. 1196-1204, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612820666141013150714. Acesso em: 02 ago. 2024.
    • APA

      Maranhão, R. C., & Leite, A. C. de A. (2015). Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, 21( 9), 1196-1204. doi:10.2174/1381612820666141013150714
    • NLM

      Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1381612820666141013150714
    • Vancouver

      Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2174/1381612820666141013150714

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024